182 related articles for article (PubMed ID: 3954726)
1. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.
Ballard FJ; Read LC; Francis GL; Bagley CJ; Wallace JC
Biochem J; 1986 Jan; 233(1):223-30. PubMed ID: 3954726
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.
Ballard FJ; Ross M; Upton FM; Francis GL
Biochem J; 1988 Feb; 249(3):721-6. PubMed ID: 2965574
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of DNA synthesis in chicken muscle satellite cells by insulin and insulin-like growth factors: evidence for exclusive mediation by a type-I insulin-like growth factor receptor.
Duclos MJ; Wilkie RS; Goddard C
J Endocrinol; 1991 Jan; 128(1):35-42. PubMed ID: 1847964
[TBL] [Abstract][Full Text] [Related]
4. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts.
Kiess W; Haskell JF; Lee L; Greenstein LA; Miller BE; Aarons AL; Rechler MM; Nissley SP
J Biol Chem; 1987 Sep; 262(26):12745-51. PubMed ID: 2957378
[TBL] [Abstract][Full Text] [Related]
5. Both type I and II insulin-like growth factor receptor binding increase during lactogenesis in bovine mammary tissue.
Dehoff MH; Elgin RG; Collier RJ; Clemmons DR
Endocrinology; 1988 Jun; 122(6):2412-7. PubMed ID: 2967174
[TBL] [Abstract][Full Text] [Related]
6. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.
Centrella M; McCarthy TL; Canalis E
Endocrinology; 1990 Jan; 126(1):39-44. PubMed ID: 2152868
[TBL] [Abstract][Full Text] [Related]
7. Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.
Read LC; Ballard FJ; Francis GL; Baxter RC; Bagley CJ; Wallace JC
Biochem J; 1986 Jan; 233(1):215-21. PubMed ID: 3513757
[TBL] [Abstract][Full Text] [Related]
8. Interaction of insulin-like growth factor I with porcine thyroid cells cultured in monolayer.
Saji M; Tsushima T; Isozaki O; Murakami H; Ohba Y; Sato K; Arai M; Mariko A; Shizume K
Endocrinology; 1987 Aug; 121(2):749-56. PubMed ID: 3036481
[TBL] [Abstract][Full Text] [Related]
9. Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II.
Francis GL; Owens PC; McNeil KA; Wallace JC; Ballard FJ
J Endocrinol; 1989 Sep; 122(3):681-7. PubMed ID: 2809477
[TBL] [Abstract][Full Text] [Related]
10. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding.
Ballard FJ; Francis GL; Ross M; Bagley CJ; May B; Wallace JC
Biochem Biophys Res Commun; 1987 Dec; 149(2):398-404. PubMed ID: 2962574
[TBL] [Abstract][Full Text] [Related]
11. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding.
Szabo L; Mottershead DG; Ballard FJ; Wallace JC
Biochem Biophys Res Commun; 1988 Feb; 151(1):207-14. PubMed ID: 2450535
[TBL] [Abstract][Full Text] [Related]
12. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.
Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL
Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497
[TBL] [Abstract][Full Text] [Related]
13. Comparison of insulin and insulin-like growth factor I receptors from rat skeletal muscle and L-6 myocytes.
Burant CF; Treutelaar MK; Allen KD; Sens DA; Buse MG
Biochem Biophys Res Commun; 1987 Aug; 147(1):100-7. PubMed ID: 2958004
[TBL] [Abstract][Full Text] [Related]
14. Characterization and regulations of the receptor for insulin-like growth factor-I in the FRTL-5 rat thyroid follicular cell line.
Tramontano D; Moses AC; Picone R; Ingbar SH
Endocrinology; 1987 Feb; 120(2):785-90. PubMed ID: 2948816
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture.
Hossenlopp P; Seurin D; Segovia B; Portolan G; Binoux M
Eur J Biochem; 1987 Dec; 170(1-2):133-42. PubMed ID: 2961564
[TBL] [Abstract][Full Text] [Related]
16. The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor.
Ewton DZ; Falen SL; Florini JR
Endocrinology; 1987 Jan; 120(1):115-23. PubMed ID: 2946572
[TBL] [Abstract][Full Text] [Related]
17. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.
Rutanen EM; Pekonen F; Mäkinen T
J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785
[TBL] [Abstract][Full Text] [Related]
18. Interaction of insulin-like growth factor II with rat chondrocytes: receptor binding, internalization, and degradation.
Sessions CM; Emler CA; Schalch DS
Endocrinology; 1987 May; 120(5):2108-16. PubMed ID: 2436896
[TBL] [Abstract][Full Text] [Related]
19. Structural and immunohistochemical characterization of insulin-like growth factor I and II receptors in the murine central nervous system.
Ocrant I; Valentino KL; Eng LF; Hintz RL; Wilson DM; Rosenfeld RG
Endocrinology; 1988 Aug; 123(2):1023-34. PubMed ID: 2969324
[TBL] [Abstract][Full Text] [Related]
20. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts.
Bach LA; Salemi R; Leeding KS
Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
